Wynzora

Wynzora is a topical corticosteroid and vitamin D3 analog combination for skin conditions. It combines betamethasone and calcipotriol to reduce inflammation and skin cell overgrowth. Wynzora cream is designed for once-daily application on affected areas. Suitable for adults with psoriasis and related skin concerns.

Wynzora is used to treat plaque psoriasis, a chronic skin condition causing red, scaly patches. It helps reduce inflammation, itching, and scaling by combining a steroid with a vitamin D3 derivative. Wynzora is typically applied to visible psoriasis plaques on the body, excluding the face and groin. It is not a cure but can manage symptoms effectively.

Wynzora works by slowing skin cell growth and reducing redness and swelling. Many users notice improved skin texture and reduced discomfort within a few weeks of consistent use. The cream is lightweight and absorbs quickly, leaving minimal residue. Results vary, and some may experience temporary dryness or mild irritation at the application site.

Wynzora is for external use only and should not be applied to broken or infected skin. Avoid contact with eyes, mouth, or mucous membranes. Wash hands before and after applying to prevent accidental spread. Do not cover treated areas with bandages or dressings unless directed. Keep out of reach of children and pets.

Avoid using Wynzora with other strong topical steroids or vitamin D products to prevent excessive absorption. Inform your healthcare provider about all medications, including over-the-counter creams and supplements. Alcohol-based products may increase skin dryness or irritation. No known interactions with common oral medications have been widely reported.